Erythropoietin may improve anemia in patients with autoimmune hemolytic anemia associated with reticulocytopenia. (yeni pencere açar)

Arbach O, Funck R, Seibt F, Salama A.

Kaynak‎: Transfus Med Hemother 2012;39(3):221-3.

İndeks‎: PubMed 22851939

DOI‎: 10.1159/000339260

https://www.ncbi.nlm.nih.gov/pubmed/22851939 (yeni pencere açar)

The changing spectrum of drug-induced immune hemolytic anemia. (yeni pencere açar)

Arndt PA, Garratty G.

Kaynak‎: Semin Hematol 2005;42(3):137-44.

İndeks‎: PubMed 16041663

https://www.ncbi.nlm.nih.gov/pubmed/16041663 (yeni pencere açar)

Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies. (yeni pencere açar)

Barcellini W, Zaja F, Zaninoni A, Imperiali FG, Battista ML, Di Bona E, Fattizzo B, Consonni D, Cortelezzi A, Fanin R, Zanella A.

Kaynak‎: Blood 2012;119(16):3691-7.

İndeks‎: PubMed 22267606

DOI‎: 10.1182/blood-2011-06-363556

https://www.ncbi.nlm.nih.gov/pubmed/22267606 (yeni pencere açar)

Autoimmune hemolytic anemia. (yeni pencere açar)

Gehrs BC, Friedberg RC.

Kaynak‎: Am J Hematol 2002;69(4):258-71.

İndeks‎: PubMed 11921020

https://www.ncbi.nlm.nih.gov/pubmed/11921020 (yeni pencere açar)

Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias. (yeni pencere açar)

Gómez-Almaguer D, Solano-Genesta M, Tarín-Arzaga L, Herrera-Garza JL, Cantú-Rodríguez OG, Gutiérrez-Aguirre CH, Jaime-Pérez JC.

Kaynak‎: Blood 2010;116(23):4783-5.

İndeks‎: PubMed 20841509

DOI‎: 10.1182/blood-2010-06-291831

https://www.ncbi.nlm.nih.gov/pubmed/20841509 (yeni pencere açar)

A case of late-onset systemic lupus erythematosus with severe anemia. (yeni pencere açar)

Matsumoto M, Kaieda S, Honda S, Ida H, Hoshino T, Fukuda T.

Kaynak‎: Kurume Med J 2013;60(1):25-8.

İndeks‎: PubMed 23925156

https://www.ncbi.nlm.nih.gov/pubmed/23925156 (yeni pencere açar)

High-dose cyclophosphamide for refractory autoimmune hemolytic anemia. (yeni pencere açar)

Moyo VM, Smith D, Brodsky I, Crilley P, Jones RJ, Brodsky RA.

Kaynak‎: Blood 2002;100(2):704-6.

İndeks‎: PubMed 12091370

DOI‎: 10.1182/blood-2002-01-0087

https://www.ncbi.nlm.nih.gov/pubmed/12091370 (yeni pencere açar)

Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia. (yeni pencere açar)

Zecca M, De Stefano P, Nobili B, Locatelli F.

Kaynak‎: Blood 2001;97(12):3995-7.

İndeks‎: PubMed 11389047

https://www.ncbi.nlm.nih.gov/pubmed/11389047 (yeni pencere açar)

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. (yeni pencere açar)

Zecca M, Nobili B, Ramenghi U, Perrotta S, Amendola G, Rosito P, Jankovic M, Pierani P, De Stefano P, Bonora MR, Locatelli F.

Kaynak‎: Blood 2003;101(10):3857-61.

İndeks‎: PubMed 12531800

DOI‎: 10.1182/blood-2002-11-3547

https://www.ncbi.nlm.nih.gov/pubmed/12531800 (yeni pencere açar)